Skip to content

A Randomized, Controlled and Multicenter Trial of Shuotong Ureteroscopy and Flexible Ureteroscopy for 1-3 Renal Calculi

A randomized, controlled and multicenter Trial of Shuotong Ureteroscopy and Flexible Ureteroscopy for 1-3 Renal Calculi

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015481
Enrollment
Unknown
Registered
2018-04-02
Start date
2018-04-01
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal calculi

Interventions

Control group:Flexible ureterscope
Experimental Group:Shuotong ureteroscope

Sponsors

Xiangya Hospital Affiliated to Central South University School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-75 years male or female, be able to tolerate the surgery; (2) renal stones' diameter between 1.5 and 3.0cm confirmed by imaging test(IVU, renal CT scan or CTU ); (3) If combined with contralateral renal calculi, the anterior operative side is included; (4) Agree to participate in this clinical study, complete postoperative follow-up and sign the informed consent

Exclusion criteria

Exclusion criteria: (1) Coagulopathy or currently on anti-coagulation therapy; (2) InfectionUncontrolled urinary tract infection, pyonephrosis, sepsis; (3) Any urological anatomical factors that can fail to operate the endoscopic surgery; (4) Intolerant of Anesthesiologists; (5) Comorbidities that interfere with the participation or completion of the study, e.g. myocardial infarction, stroke, congestive heart failure, severe chronic respiratory lung disease, cancer, uncontrolled diabetes mellitus, pregnancy, severe systemic diseases or psychosis; (6) No plan to return to our hospital for D-J stent removal and relevant follow-up a month after surgery; (7) Currently involved in other clinical studies; (8) Refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
stone free rate;Successful rate;Operative complication;Operation time;

Secondary

MeasureTime frame
Postoperative hospital stay;bleeding;Postoperative use of analgesic;hospitalization fees;

Countries

China

Contacts

Public ContactXiaobo, Zhang

International Sugical Ward, Xiangya Hospital Affiliated to Central South University School

xiaobozxb@163.com+86 13508474169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026